Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blanchette

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of Managed Care Pharmacy : JMCP|March 12, 2008
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage populationChristopher M Blanchette, Benjamin Gutierrez, Caron Ory, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cachexia in the Us Health Care SystemJ Noone, C M Blanchette, D Roy, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|March 27, 2010
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD managementDouglas W Mapel, Judith S Hurley, Anand A Dalal, et al.
BMC Surgery|August 17, 2014
A cross-sectional retrospective analysis of the regionalization of complex surgeryJames Studnicki, Christopher Craver, Christopher M Blanchette, et al.
Scandinavian Journal of Infectious Diseases|September 30, 2014
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing EnterobacteriaceaeLisa M Blanchette, Joseph L Kuti, David P Nicolau, et al.
Drugs in Context|August 20, 2016
Evaluating cost benefits of combination therapies for advanced melanomaIvar S Jensen, Emily Zacherle, Christopher M Blanchette, et al.
Health Services Research|March 29, 2008
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverageLinda Simoni-Wastila, Ilene H Zuckerman, Thomas Shaffer, et al.
American Health & Drug Benefits|January 8, 2020
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United StatesMichael C Runken, Joshua M Noone, Christopher M Blanchette, et al.
Clinical Therapeutics|August 19, 2007
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimenKaren L Rascati, Manabu Akazawa, Michael Johnsrud, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 30, 2006
The chorionic bump: a first-trimester pregnancy sonographic finding associated with a guarded prognosisRobert D Harris, Corey Couto, Clara Karpovsky, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of Managed Care Pharmacy : JMCP|March 12, 2008
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage populationChristopher M Blanchette, Benjamin Gutierrez, Caron Ory, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cachexia in the Us Health Care SystemJ Noone, C M Blanchette, D Roy, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|March 27, 2010
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD managementDouglas W Mapel, Judith S Hurley, Anand A Dalal, et al.
BMC Surgery|August 17, 2014
A cross-sectional retrospective analysis of the regionalization of complex surgeryJames Studnicki, Christopher Craver, Christopher M Blanchette, et al.
Scandinavian Journal of Infectious Diseases|September 30, 2014
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing EnterobacteriaceaeLisa M Blanchette, Joseph L Kuti, David P Nicolau, et al.
Drugs in Context|August 20, 2016
Evaluating cost benefits of combination therapies for advanced melanomaIvar S Jensen, Emily Zacherle, Christopher M Blanchette, et al.
Health Services Research|March 29, 2008
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverageLinda Simoni-Wastila, Ilene H Zuckerman, Thomas Shaffer, et al.
American Health & Drug Benefits|January 8, 2020
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United StatesMichael C Runken, Joshua M Noone, Christopher M Blanchette, et al.
Clinical Therapeutics|August 19, 2007
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimenKaren L Rascati, Manabu Akazawa, Michael Johnsrud, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 30, 2006
The chorionic bump: a first-trimester pregnancy sonographic finding associated with a guarded prognosisRobert D Harris, Corey Couto, Clara Karpovsky, et al.
Pageof 12